DATE15 Jul

NIFTY 24,078 ▲ 0.11%BANK NIFTY 57,758 ▲ 0.51%NIFTY IT 28,532 ▼ 0.67%NIFTY PHARMA 26,004 ▲ 0.37%PATANJALI 348 ▼ 14.64%NUVOCO 377 ▲ 10.50%GABRIEL 1,354 ▲ 8.48%AEGISLOG 1,321 ▲ 8.07%ATHERENERG 1,296 ▲ 7.87%LTTS 3,508 ▲ 6.53%GROWW 216 ▲ 6.15%JUBLPHARMA 1,028 ▲ 5.54%FLUOROCHEM 4,132 ▲ 5.29%TRITURBINE 639 ▲ 5.20%NIFTY 24,078 ▲ 0.11%BANK NIFTY 57,758 ▲ 0.51%NIFTY IT 28,532 ▼ 0.67%NIFTY PHARMA 26,004 ▲ 0.37%PATANJALI 348 ▼ 14.64%NUVOCO 377 ▲ 10.50%GABRIEL 1,354 ▲ 8.48%AEGISLOG 1,321 ▲ 8.07%ATHERENERG 1,296 ▲ 7.87%LTTS 3,508 ▲ 6.53%GROWW 216 ▲ 6.15%JUBLPHARMA 1,028 ▲ 5.54%FLUOROCHEM 4,132 ▲ 5.29%TRITURBINE 639 ▲ 5.20%

Morning brief · Thursday, 16 July 2026

SBI Mutual Fund takes near 10 percent stake in Relaxo

Market pulse

Indian markets ended a mixed session with a slight gain, as strength in banking and pharmaceutical stocks helped the Nifty close just above 24,000. While the broader market was buoyed by notable gains in individual names like Nuvoco and Gabriel, the IT sector saw declines and Patanjali experienced a significant drop.

From the investor's mind

One post worth your time, explained

@itsTarH · on X

Tar observes that the current emergence of lab-grown diamond retail chains mirrors Titan's successful strategy in the jewellery market. When Titan entered the scene, the gold market was largely unorganized, lacking common standards for quality and pricing. Titan differentiated itself and gained market share by introducing standardization and transparent pricing, effectively professionalizing the segment. Similarly, Tar suggests that lab-grown diamond retailers are poised to replicate this success by bringing structure and clarity to their nascent market.

Yesterday's big moves